BIOMEA FUSION INC. -

Biomea Fusion to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference

15 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022

08 Mar 2022 17:15:00 By Nasdaq GlobeNewswire

Biomea Fusion Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

28 Feb 2022 15:05:01 By Nasdaq GlobeNewswire

Biomea Fusion Announces Appointment of Steve Morris, M.D. as Chief Medical Officer

01 Feb 2022 05:30:00 By Nasdaq GlobeNewswire

Biomea Fusion Announces First Patient Dosed

25 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Biomea Fusion Announces Participation at the H.C. Wainwright 2022 BioConnect Conference

11 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven Different Tumor Types and in Diabetes for BMF-219

10 Jan 2022 07:30:01 By Nasdaq GlobeNewswire

Biomea Fusion Releases Pre-Clinical Data with BMF-219 in Diabetes

06 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Biomea Fusion Moves into New Headquarters and Expands R&D Facility

04 Jan 2022 12:30:14 By Nasdaq GlobeNewswire

Biomea Fusion to Present at the 40th Annual J.P. Morgan Healthcare Conference

21 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Biomea Fusion to be added to NASDAQ Biotechnology Index

14 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Biomea Fusion to Participate in Two Upcoming Investor Conferences

10 Nov 2021 13:00:00 By Nasdaq GlobeNewswire

Biomea Fusion Publishes Abstract on BMF-219 at ASH Annual Meeting

04 Nov 2021 09:49:38 By Nasdaq GlobeNewswire

Biomea Fusion Reports Third Quarter 2021 Financial Results and Business Highlights

03 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Biomea Fusion Announces FDA Clearance of Investigational New Drug Application for Irreversible Menin Inhibitor BMF-219

16 Sep 2021 12:35:00 By Nasdaq GlobeNewswire

Biomea Fusion Reports Second Quarter 2021 Financial Results and Business Highlights

11 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer

28 Jun 2021 18:10:00 By Nasdaq GlobeNewswire

Biomea Fusion Reports First Quarter 2021 Financial Results and Business Highlights

27 May 2021 15:05:00 By Nasdaq GlobeNewswire

Biomea Announces Closing of Initial Public Offering

20 Apr 2021 15:05:00 By Nasdaq GlobeNewswire